References
- Benson MD, James S, Scott K, et al. Leukocyte chemotactic factor 2: a novel renal amyloid protein. Kidney Int. 2008;74(2):218–222. doi:10.1038/ki.2008.152.
- Said SM, Sethi S, Valeri AM, et al. Characterization and outcomes of renal leukocyte chemotactic factor 2-associated amyloidosis. Kidney Int. 2014;86(2):370–377. doi:10.1038/ki.2013.558.
- Abe R, Katoh N, Takahashi Y, et al. Distribution of amyloidosis subtypes based on tissue biopsy site – consecutive analysis of 729 patients at a single amyloidosis center in Japan. Pathol Int. 2021;71(1):70–79. doi:10.1111/pin.13041.
- Tasaki M, Ueda M, Hoshii Y, et al. A novel age-related venous amyloidosis derived from EGF-containing fibulin-like extracellular matrix protein 1. J Pathol. 2019;247(4):444–455. doi:10.1002/path.5203.
- Li DY, Liu D, Wang SX, et al. Renal leukocyte chemotactic factor 2 (ALECT2)-associated amyloidosis in Chinese patients. Amyloid. 2020;27(2):134–141. doi:10.1080/13506129.2020.1722097.